» Articles » PMID: 33628370

Radiation Can Regulate the Expression of MiRNAs Associated with Osteogenesis and Oxidation in Exosomes from Peripheral Blood Plasma

Overview
Publisher Wiley
Date 2021 Feb 25
PMID 33628370
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Radiotherapy is a common therapy in head and neck tumors, which may cause a side effect radiation bone injury (RBI). Furthermore, it has been investigated that microRNA (miRNA) expression levels were altered after radiotherapy. Exosomes play a role in bone formation as miRNA containers, while radiation affects exosomes composition, secretion, and function. So, our objective is to explore changes in miRNA levels during bone formation after radiotherapy and identify the differentially expressed miRNAs (DE-miRs) in plasma exosomes during the process of osteogenesis related to irradiation.

Materials And Methods: In this study, we analyzed nine samples from three rabbits exposed twice to radiation (15 Gy each) and detected DE-miRs from irradiated plasma exosomes during the process of osteogenesis by RNA sequencing. Further, we identified DE-miRs with significant differences and predicted their target genes via the bioinformatics analysis tools Targetscan v7.2 and miRPathDB v2.0. Finally, we identified radiation-responsive miRNAs and predicted their target genes during osteogenesis.

Results: Taken together, we have identified some DE-miRs in irradiated plasma exosomes, which were involved in several vital signaling pathways related to bone physiology, such as the Wnt pathway, MAPK cascade, and calcium modulating pathway.

Conclusions: We have found that plasma exosomes are one of the ways by which radiation can affect bone metabolism and regeneration. However, the specific mechanisms of how these plasma exosomal miRNAs mediate the osteogenesis pathways must be further investigated. . Radiotherapy may cause radiation bone injury, and miRNA expression levels in rabbit plasma exosomes are altered after radiotherapy. High-throughput RNA sequencing can identify the differentially expressed miRNAs in irradiated plasma exosomes during the process of osteogenesis. These findings make sense to develop novel therapeutic strategies for treating radiation-induced bone injury disorders.

Citing Articles

Non-bone-derived exosomes: a new perspective on regulators of bone homeostasis.

Wang P, Shao W, Li Z, Wang B, Lv X, Huang Y Cell Commun Signal. 2024; 22(1):70.

PMID: 38273356 PMC: 10811851. DOI: 10.1186/s12964-023-01431-7.


Research Progress of Exosomes in Bone Diseases: Mechanism, Diagnosis and Therapy.

Meng F, Xue X, Yin Z, Gao F, Wang X, Geng Z Front Bioeng Biotechnol. 2022; 10:866627.

PMID: 35497358 PMC: 9039039. DOI: 10.3389/fbioe.2022.866627.


Potential mechanism of action of Jing Fang Bai Du San in the treatment of COVID-19 using docking and network pharmacology.

Li J, Zhang K, Bao J, Yang J, Wu C Int J Med Sci. 2022; 19(2):213-224.

PMID: 35165507 PMC: 8795796. DOI: 10.7150/ijms.67116.


Therapeutic implications of exosomes in the treatment of radiation injury.

Dai S, Wen Y, Luo P, Ma L, Liu Y, Ai J Burns Trauma. 2022; 10:tkab043.

PMID: 35071650 PMC: 8778593. DOI: 10.1093/burnst/tkab043.

References
1.
Xu S, Wang J, Ding N, Hu W, Zhang X, Wang B . Exosome-mediated microRNA transfer plays a role in radiation-induced bystander effect. RNA Biol. 2015; 12(12):1355-63. PMC: 4829325. DOI: 10.1080/15476286.2015.1100795. View

2.
Mo L, Song M, Huang Q, Guan H, Liu X, Xie D . Exosome-packaged miR-1246 contributes to bystander DNA damage by targeting LIG4. Br J Cancer. 2018; 119(4):492-502. PMC: 6134031. DOI: 10.1038/s41416-018-0192-9. View

3.
Mognato M, Celotti L . MicroRNAs Used in Combination with Anti-Cancer Treatments Can Enhance Therapy Efficacy. Mini Rev Med Chem. 2015; 15(13):1052-62. PMC: 4997954. DOI: 10.2174/1389557515666150709115355. View

4.
Kalluri R, LeBleu V . The biology function and biomedical applications of exosomes. Science. 2020; 367(6478). PMC: 7717626. DOI: 10.1126/science.aau6977. View

5.
Hua X, Xiao Y, Pan W, Li M, Huang X, Liao Z . miR-186 inhibits cell proliferation of prostate cancer by targeting GOLPH3. Am J Cancer Res. 2016; 6(8):1650-60. PMC: 5004070. View